The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

K Dheda, T Perumal, H Moultrie, R Perumal… - The Lancet …, 2022 - thelancet.com
The global tuberculosis burden remains substantial, with more than 10 million people newly
ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade …

Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta …

L Martinez, O Cords, Q Liu… - The Lancet Global …, 2022 - thelancet.com
Background BCG vaccines are given to more than 100 million children every year, but there
is considerable debate regarding the effectiveness of BCG vaccination in preventing …

The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis

L Martinez, O Cords, CR Horsburgh, JR Andrews… - The Lancet, 2020 - thelancet.com
Background Tens of millions of children are exposed to Mycobacterium tuberculosis globally
every year; however, there are no contemporary estimates of the risk of develo** …

Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults

D Menzies, M Adjobimey, R Ruslami… - … England Journal of …, 2018 - Mass Medical Soc
Background A 9-month regimen of isoniazid can prevent active tuberculosis in persons with
latent tuberculosis infection. However, the regimen has been associated with poor …

Levofloxacin for the prevention of multidrug-resistant tuberculosis in Vietnam

GJ Fox, NV Nhung, N Cam Binh, NB Hoa… - … England Journal of …, 2024 - Mass Medical Soc
Background Prevention of drug-resistant tuberculosis is a global health priority. However,
trials evaluating the effectiveness of treating Mycobacterium tuberculosis infection among …

What we know about tuberculosis transmission: an overview

G Churchyard, P Kim, NS Shah… - The Journal of …, 2017 - academic.oup.com
Tuberculosis remains a global health problem with an enormous burden of disease,
estimated at 10.4 million new cases in 2015. To stop the tuberculosis epidemic, it is critical …

Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives

SM Gygli, S Borrell, A Trauner… - FEMS microbiology …, 2017 - academic.oup.com
Antibiotic-resistant Mycobacterium tuberculosis strains are threatening progress in
containing the global tuberculosis epidemic. Mycobacterium tuberculosis is intrinsically …

The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis

H Alsdurf, PC Hill, A Matteelli, H Getahun… - The Lancet Infectious …, 2016 - thelancet.com
Background WHO estimates that a third of the world's population has latent tuberculosis
infection and that less than 5% of those infected are diagnosed and treated to prevent …

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

MJA Reid, N Arinaminpathy, A Bloom, BR Bloom… - The Lancet, 2019 - thelancet.com
Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Effectiveness of contact tracing in the control of infectious diseases: a systematic review

AD Hossain, J Jarolimova, A Elnaiem… - The Lancet Public …, 2022 - thelancet.com
Background Contact tracing is used for multiple infectious diseases, most recently for COVID-
19, but data regarding its effectiveness in disease control are scarce. To address this …